Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)

NACompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

September 23, 2013

Primary Completion Date

December 2, 2015

Study Completion Date

January 18, 2016

Conditions
Left Ventricular Hypertrophy
Interventions
PROCEDURE

Tissue biopsies

"It is commonly accepted that the diagnosis of cardiac amyloidosis may be based on presence of characteristic cardiac abnormalities in echography, associated with the detection of bi-refractive appearance deposits in polarized light after congo red staining of a biopsy fragment.~Usually a biopsy of the abdominal fat or salivary glands can suffice. More rarely, in case of persistent doubt (eg negativity of congo red despite a characteristic appearance, which may occur in 20 to 30% of cases), it will be necessary to perform an endomyocardial biopsy (EMB)."

Trial Locations (2)

97100

Centre Hospitalier de Basse-Terre, Basse-Terre

97220

CHU de Martinique, La Trinité

All Listed Sponsors
lead

University Hospital Center of Martinique

OTHER

NCT03322319 - Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose) | Biotech Hunter | Biotech Hunter